Official publication of Rawalpindi Medical University
Frequency of pregnancy induced hypertension and its association with elevated serum beta human chorionic gonadotropin levels during mid trimester of pregnancy

Supplementary Files

PDF

How to Cite

1.
Habib S, Haq AI ul, Bashir S, Sadiq N, Majeed N, Waheed N. Frequency of pregnancy induced hypertension and its association with elevated serum beta human chorionic gonadotropin levels during mid trimester of pregnancy. JRMC [Internet]. 2023 Jun. 24 [cited 2024 Apr. 16];27(2). Available from: http://www.journalrmc.com/index.php/JRMC/article/view/1902

Abstract

Objective: To determine the frequency of PIH amongst elevated beta-hCG levels and non-elevated beta-hCG in the mid-trimester of pregnancy.

Materials and Methods: It was Descriptive case series conducted for six months (02-12-2019 to 02-06-2020) in OPD of Gynae Unit-II, Holy Family Hospital, Rawalpindi. A total of one hundred and twenty-two (n=122) normotensive pregnant females at 13-20 weeks gestational age and 18-35 years of maternal age were selected in this study after informed consent from every patient. The frequency of PIH in patients with elevated serum beta-hCG was measured. Data were analyzed using SPSS version 20. Effect modifiers were controlled by stratification. A p-value of ≤ 0.05 was considered significant.

Results: Mean beta-hCG levels in the total study population were found to be 7305.09±3900.64 IU/mL. Median b-hCG levels in our study population were noted as 6936.15 IU/mL. Pregnancy-induced hypertension was found positive in 16 (13.1%) patients. Raised beta-hCG levels were present in 10 (8.2%) patients. The frequency of PIH in raised beta-HCG levels was found in 7/10 (70%) of patients. We found a statistically significant (p-value ≤ 0.05) difference in the frequency of PIH among patients with elevated and not-elevated beta-hCG levels.

Conclusion: It is evident from my study that patients with raised levels of serum β-hCG during mid-trimester pregnancy are at increased risk to develop hypertensive disorders of pregnancy. We further elaborated that there is a statistically significant difference in various effect modifiers such as maternal age, gestational age, residential status, and BMI  for developing  PIH among patients with elevated and non-elevated beta-hCG levels.

https://doi.org/10.37939/jrmc.v27i2.1902

References

Upadya M, Rao ST. Hypertensive disorders in pregnancy. Indian J Anaesth. 2018;62:675–81.

Mehta B, Kumar V, Chawla S, Sachdeva S, Mohapatra D. Hypertension in Pregnancy: A Community-Based Study. Indian J Community Med. 2015;40:273–8.

Aronow WS. Hypertensive disorders in pregnancy. Ann Transl Med. 2017;5:266-7.

Sajith M, Nimbargi V, Modi A, Sumariya R, Pawar A. Incidence of pregnancy-induced hypertension and prescription pattern of antihypertensive drugs in pregnancy. Int J Pharm Sci Res. 2014;5:163-70.

Magee LA, Sharma S, Nathan HL, Adetoro OO, Bellad MB, Goudar S, et al. The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: A prospective population-level analysis. PLoS Med. 2019;16:e1002783.

Muti M, Tshimanga M, Notion GT, Bangure D, Chonzi P. Prevalence of pregnancy-induced hypertension and pregnancy outcomes among women seeking maternity services in Harare, Zimbabwe. BMC Cardiovasc Disord. 2015;15:111-3.

Kour G, Kour S. Serum βhCG levels between 13-20 weeks gestation can predict the development of pregnancy-induced hypertension. NJOG. 2018;24:12-4.

Munirah M, Khalidah MB, Dian Nasriana N, Hanita O, Nor Azlin M. Early Second Trimester hCG of Maternal Serum as Predictor Marker for Pregnancy Induced Hypertension. Med & Health. 2018;13:143-52.

Sharma V, Sharma P, Firdous N. BETA HCG in Mid Trimester as a Predictor of Pregnancy Induced Hypertension. Int J Sci Res. 2016;5:303-5.

Chowdhary H, Khurshid R, Parveen S, Yousuf S, Tali SH, Shah ZA. Utility of second-trimester beta HCG levels in the prediction of gestational hypertension: a prospective cohort study. Int J Reprod Contracept Obstet Gynecol. 2017;6:1040-4.

Ravankar VM, Narmada L. Assessment of serum βhCG and lipid profile in the early second trimester as predictors of hypertensive disorders of pregnancy. Int J Gynaecol Obstet. 2017;138:331-4.

Vanitha V, Shanthi S, Rani SU. To Study the Role of Maternal Serum Beta hCG at 13–20 Weeks of Gestation in Prediction of Pre-Eclampsia. Obstet Gynaecol. 2016;5:39-41.

Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222. Obstet Gynecol. 2020;135:1492-1505.

. Brown MA, Magee LA, Kenny LC. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension. 2018;72:24-30.

Sisti G, Colombi I. New blood pressure cut off for preeclampsia definition: 130/80 mmHg. Eur J Obstet Gynecol Reprod Biol. 2019;240:322-30.

Payne B, Magee LA, von Dadelszen P. Assessment, surveillance and prognosis in pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 2011;25:449-55.

Magee LA, Pels A, Helewa M. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36:416-25.

Tranquilli AL, Dekker G, Magee L. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2014;4:97-106.

Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103:981-90.

Abalos E, Cuesta C, Grosso AL. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170:1-9.

Lisonkova S, Sabr Y, Mayer C. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol. 2014;124:771-80.

Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: a systematic review of controlled studies. BMJ. 2005;330:565-75.

Bartsch E, Medcalf KE, Park AL. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753-65.

van Rijn BB, Hoeks LB, Bots ML. Outcomes of subsequent pregnancy after a first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol. 2006;195:723-30.

Gaugler-Senden IP, Berends AL, de Groot CJ, Steegers EA. Severe, very early onset preeclampsia: subsequent pregnancies and future parental cardiovascular health. Eur J Obstet Gynecol Reprod Biol. 2008;140:171-80.

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.